Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Bridgewater Bancshares IncBWB · Entity 2317 | PRESIDENT & CFO | June 05, 2026 | June 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Bridgewater Bancshares Inc
Report date June 05, 2026 · Filed June 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 118,501 |
Ending reported balance
After 2026-06-05 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-06-05 · Exercise / conversion · Acquired 7,000 · Balance 125,501 Row 2 · 2026-06-05 · Sale · Disposed 7,000 · Balance 118,501 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.95 to $19.02, inclusive. The reporting person undertakes to provide to Bridgewater Bancshares, Inc., any security holder of Bridgewater Bancshares, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price set forth in this footnote to this Form 4. |
| Option to buySEC Table II · derivative / convertible security · Conversion / exercise price $7.47 · Expires 2027-09-30 | Direct | 129,500 |
Reported balance
After 2026-06-05 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-06-05 · Exercise / conversion · Disposed 7,000 · Balance 129,500 F2: Options to buy granted under the 2012 Combined Incentive and Non-Statutory Stock Option Plan. F3: Options exercisable in 20% increments on the first five anniversaries of the date of the grant which was 10/1/2017. |
| Option to buySEC Table II · derivative / convertible security · Conversion / exercise price $12.92 · Expires 2029-12-06 | Direct | 23,000 |
Reported balance
Holding disclosure · report date 2026-06-05 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 23,000 F4: Options to buy granted under the 2017 Combined Incentive and Non-Statutory Stock Option Plan. F5: Options exercisable in 25% increments on the first four anniversaries of the date of the grant which was 12/6/2019. |
| Option to buySEC Table II · derivative / convertible security · Conversion / exercise price $17.50 · Expires 2032-02-01 | Direct | 20,000 |
Reported balance
Holding disclosure · report date 2026-06-05 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 20,000 F4: Options to buy granted under the 2017 Combined Incentive and Non-Statutory Stock Option Plan. F6: Options exercisable in 25% increments on the first four anniversaries of the date of the grant which was 2/1/2022. |
| Option to buySEC Table II · derivative / convertible security · Conversion / exercise price $17.50 · Expires 2032-02-01 | Direct | 30,000 |
Reported balance
Holding disclosure · report date 2026-06-05 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 30,000 F2: Options to buy granted under the 2012 Combined Incentive and Non-Statutory Stock Option Plan. F6: Options exercisable in 25% increments on the first four anniversaries of the date of the grant which was 2/1/2022. |
| Common StockSEC Table I · non-derivative | IndirectBy Spouse IRA | 1,000 |
Reported balance
Holding disclosure · report date 2026-06-05 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 1,000 |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.95 to $19.02, inclusive. The reporting person undertakes to provide to Bridgewater Bancshares, Inc., any security holder of Bridgewater Bancshares, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price set forth in this footnote to this Form 4.
F2: Options to buy granted under the 2012 Combined Incentive and Non-Statutory Stock Option Plan.
F3: Options exercisable in 20% increments on the first five anniversaries of the date of the grant which was 10/1/2017.
F4: Options to buy granted under the 2017 Combined Incentive and Non-Statutory Stock Option Plan.
F5: Options exercisable in 25% increments on the first four anniversaries of the date of the grant which was 12/6/2019.
F6: Options exercisable in 25% increments on the first four anniversaries of the date of the grant which was 2/1/2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 20, 2019 Filed Dec 23, 2019 20:22 UTC | Bridgewater Bancshares Inc BWB · Entity 2317 | Exercise / conversionCommon Stock | 5,000 | $3.58 | $17,900.00 |
DisclosureSEC source: 0001179110-19-013117 · edgar.xml · nonDerivative · entry 1 Chybowski Joseph M. · CIK 0001732715 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,667 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 06, 2019 Filed Dec 10, 2019 16:52 UTC | Bridgewater Bancshares Inc BWB · Entity 2317 | GrantOption to buy · Derivative | 23,000 | $0.00 Strike: $12.92 | $0.00 |
DisclosureSEC source: 0001179110-19-012583 · edgar.xml · derivative · entry 3 Chybowski Joseph M. · CIK 0001732715 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,000 Underlying: Common Stock · 23,000 shares Expires 2029-12-06 F1 · security: Options to buy granted under the 2017 Combined Incentive and Non-Statutory Stock Option Plan. F2 · derivative.exercise_date: Options exercisable in 25% increments on the first four anniversaries of the date of the grant which was 12/6/2019. Read SEC document |
| December 06, 2019 Filed Dec 10, 2019 16:52 UTC | Bridgewater Bancshares Inc BWB · Entity 2317 | GrantCommon Stock | 8,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-012583 · edgar.xml · nonDerivative · entry 1 Chybowski Joseph M. · CIK 0001732715 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,667 Read SEC document |
| October 30, 2019 Filed Oct 30, 2019 16:05 UTC | Bridgewater Bancshares Inc BWB · Entity 2317 | PurchaseCommon Stock | 500 | $12.55 | $6,273.60 |
DisclosureSEC source: 0001179110-19-011279 · edgar.xml · nonDerivative · entry 1 Chybowski Joseph M. · CIK 0001732715 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 F1 · kind: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on July 30, 2019. Read SEC document |
| August 30, 2019 Filed Sep 3, 2019 20:15 UTC | Bridgewater Bancshares Inc BWB · Entity 2317 | PurchaseCommon Stock | 500 | $11.30 | $5,650.00 |
DisclosureSEC source: 0001179110-19-010009 · edgar.xml · nonDerivative · entry 1 Chybowski Joseph M. · CIK 0001732715 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,500 F1 · kind: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on July 30, 2019. F2 · balance_after: Includes 2000 shares held in an IRA previously reported as indirectly owned. Read SEC document |
| October 31, 2018 Filed Nov 1, 2018 18:17 UTC | Bridgewater Bancshares Inc BWB · Entity 2317 | PurchaseCommon Stock | 1,000 | $11.05 | $11,052.50 |
DisclosureSEC source: 0001179110-18-012432 · edgar.xml · nonDerivative · entry 1 Chybowski Joseph M. · CIK 0001732715 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,000 F1 · price: The price in Column 4 is a weighted average price. These shares were purchased in two transactions at prices of $10.885 and $11.06. The reporting person undertakes to provide Bridgewater Bancshares, Inc., any security holder of Bridgewater Bancshares, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price set forth in this footnote to this Form 4. Read SEC document |
| March 16, 2018 Filed Mar 19, 2018 15:38 UTC | Bridgewater Bancshares Inc BWB · Entity 2317 | PurchaseCommon Stock | 2,000 | $11.75 | $23,500.00 |
DisclosureSEC source: 0001179110-18-004552 · edgar.xml · nonDerivative · entry 1 Chybowski Joseph M. · CIK 0001732715 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Read SEC document |
| October 01, 2017 Filed Mar 19, 2018 15:38 UTC | Bridgewater Bancshares Inc BWB · Entity 2317 | GrantOption to buy · Derivative | 150,000 | $0.00 Strike: $7.47 | $0.00 |
DisclosureSEC source: 0001179110-18-004552 · edgar.xml · derivative · entry 2 Chybowski Joseph M. · CIK 0001732715 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 150,000 shares Expires 2027-09-30 F1 · security: Option to buy granted under the 2012 Combined Incentive and Non-Statutory Stock Option Plan. F2 · derivative.exercise_date: Options exercisable in 20% increments on the first five anniversaries of the date of the grant which was 10/1/2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.